Navigation Links
MarketsandMarkets: Global Autoimmune Treatment Market Worth US$68.81 Billion by 2014
Date:9/1/2009

profiles the top forty market players and their respective autoimmune products. The report identifies and analyzes the market according to application markets for both systemic and localized autoimmune diseases, product markets, services market, and technologies market.

    Autoimmune Treatment - Applications

    - Systemic autoimmune diseases - rheumatoid arthritis, psoriasis, lupus
    and other systemic autoimmune diseases.

    - Localized autoimmune diseases - multiple sclerosis, inflammatory bowel
    disease, diabetes, thyroid and other localized autoimmune diseases.

Autoimmune Treatment - Products

Drugs, diagnostic equipments, therapeutic and monitoring equipments and other products.

Autoimmune Treatment - Services

Consultation & Diagnosis, Therapy & Monitoring, Drug Development and other services.

Autoimmune Treatment - Technologies

DMARD (disease-modifying anti-rheumatic drugs) and biologic DMARD therapy, Bridge therapy, Topical therapy, Phototherapy, Helminthic therapy, Fecal bacteriotherapy, Haematopoietic stem-cell transplantation, Recombinant technology

Analyst Briefings on 15th Sep 2009.

The Pharmaceuticals practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Global Autoimmune Treatment Market to be held on 15th Sep 2009. The briefing on the Global Autoimmune Treatment Market (2009-2014) will benefit the drug manufacturers, therapeutic and diagnostic equipment manufacturers, researchers and consultation and therapy service providers.

To register your participation, please click here http://www.marketsandmarkets.com/AnalystBriefing/analyst-briefing-global-biom aterial-market.asp

(Due to the leng
'/>"/>

SOURCE Markets and Markets
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Global Biomaterials Market Worth US$58.1 Billion by 2014
2. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
3. Elsevier Global Medical News Launches H1N1 Channel
4. NexInfo Solutions, Inc. Selected by Beckman Coulter to Design and Streamline Global Sales & Operations Planning Processes
5. PharmatrophiX, Initially Funded by the Alzheimers Drug Discovery Foundation, Announces Exclusive Global Collaboration with Elan
6. AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference
7. Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference
8. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
9. Optimer Pharmaceuticals to Present at the Canaccord Adams 29th Annual Global Growth Conference
10. Global Jatropha Hi-Tech Agricultural Training Programme (JWTP)
11. Global One Consulting Announces Exclusive Contract to Expand Saigene Biotech, Inc. Sales in Emerging Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: ... the development of autologous cell therapies, today reported ... 2015, corporate highlights, and near-term milestones.  The company,s ... www.sedar.com ,  www.edgar.com and at ... to launch its RCS-01 treatment for aging and ...
(Date:8/27/2015)... , ... August 27, 2015 , ... ... for venture capital funds, investment firms and animal health companies to hear from ... raised $160 million. Several have also received licensing agreements or distribution contracts. ...
(Date:8/27/2015)... 2015 /PRNewswire/ - Portage Biotech Inc. ("Portage") (OTC ... Pharmaceutical Holding Company Limited (Biohaven), announced today that ... of BHV-0223, a glutamate modulating agent. Biohaven filed ... recently obtained clearance from the U.S. Food and ... Portage holds 54% equity interest in Biohaven, a ...
(Date:8/27/2015)... ON , Aug. 27, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: ... three and six-month periods ended June 30, 2015. Biorem,s complete second ... www.sedar.com ). FINANCIAL HIGHLIGHTS: in ,000,s except earnings per shareThree-months ... , 2014 , 2015 , 2014 ... 9,398 , 4,433 Gross profit , 1,656 ...
Breaking Biology Technology:RepliCel Reports Second Quarter 2015 Financial Results 2RepliCel Reports Second Quarter 2015 Financial Results 3RepliCel Reports Second Quarter 2015 Financial Results 4RepliCel Reports Second Quarter 2015 Financial Results 5VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 2VetStem Biopharma, Inc. Among Seventeen Companies Selected to Present at the KC Animal Health Investment Forum on September 1st 2015 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3
... 19, 2010 Amsterdam Molecular,Therapeutics (EuroNext Amsterdam: AMT), a leader ... update in compliance with,the EU transparency directive. This report summarizes material ... , Q1 2010 Highlights, - ... Dossier validated by EMA on January 20, 2010, ...
... MOUNTAIN VIEW, Calif. , May 19 ... Schall , Ph.D., the Company,s President and Chief Executive ... Entrepreneur Of The Year® 2010 Award in Northern ... awards program recognizes entrepreneurs who demonstrate extraordinary success in ...
... , May 19 Hothead Technologies, Inc. ... the Sivix key computing fob and associated sensor monitoring ... These solutions are based upon the H.O.T.™ System, a ... the helmet of an athlete, firefighter, soldier, or other ...
Cached Biology Technology:AMT Provides Business Update for the First Quarter 2010 2AMT Provides Business Update for the First Quarter 2010 3ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California 2ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California 3ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California 4Hothead Technologies Partners with Sivix Logistics to Add Customized Handheld Monitors and Autonomous Sensors to its Product Line 2Hothead Technologies Partners with Sivix Logistics to Add Customized Handheld Monitors and Autonomous Sensors to its Product Line 3
(Date:7/31/2015)... 31. juli 2015 Den 10. internationale konference ... BGI fra den 22. - 25. oktober i ... sin 10-års fødselsdag i år. Siden starten i 2006 ... møder på ,omik,-feltet, og er en af de mest ... ICG-10 fokuserer på nylige gennembrud og fremskridt inden for ...
(Date:7/31/2015)... de 2015 La 10 th International Conference ... de BGI del 22 al 25 de octubre de 2015 en ... año, la conferencia celebra su décimo aniversario. Desde su inauguración ... de las reuniones anuales más influyentes del mundo en el ... dinámicas, entusiastas y mejores a nivel científico. ...
(Date:7/30/2015)... July 30, 2015 Cellecta, Inc., a ... function analysis and biomarker discovery, announced the release ... Library targeting all human protein coding genes. CRISPR ... out" a gene,s function. Cellecta,s new Human Whole ... screening tool so that researchers can investigate in ...
Breaking Biology News(10 mins):Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 2La 10th International Conference on Genomics (ICG-10) se llevará a cabo en octubre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2
... The 2010 Annual Meeting & OTO EXPO of the ... (AAO-HNSF), the largest meeting of ear, nose, and throat doctors ... MA. , Featuring more than 305 scientific research sessions, ... the annual meeting is a unique opportunity for journalists from ...
... paper published this week in the Proceedings of ... ecologist Dr. Emma Rosi-Marshall and colleagues report that streams ... that originate from adjacent genetically modified crops. The protein ... and plant parts are washed into stream channels. ...
... has received a $15 million grant from the National ... Research Excellence, or INBRE, program. The grant is centered ... the Department of Biological Science in the LSU College ... to strengthen the biomedical research infrastructure and work force ...
Cached Biology News:2010 AAO-HNSF new research highlights: Tuesday, Sept. 28, 2010 22010 AAO-HNSF new research highlights: Tuesday, Sept. 28, 2010 32010 AAO-HNSF new research highlights: Tuesday, Sept. 28, 2010 42010 AAO-HNSF new research highlights: Tuesday, Sept. 28, 2010 5Insecticides from genetically modified corn present in adjacent streams 2LSU receives $15 million grant from NIH to build biomedical research pipeline for Louisiana 2
The large Dodeca stainer shaking rack holds the staining trays in the large Dodeca stainer....
...
...
... Quansys Biosciences Q-Plex Array is a new ... human, mouse, and rat research. The Q-Plex ... ELISA-based test where 4 distinct capture antibodies ... a 96-well plate in a defined array. ...
Biology Products: